Prominent features of management strategies in acute coronary syndromes with the new oral antiplatelet agents

Prominent features of management strategies in acute coronary syndromes with the new oral antiplatelet agents

The novel oral P2Y12 inhibitors (prasugrel and ticagrelor) have been incorporated into the recently updated acute coronary syndrome (ACS) guidelines, as an adjunct antiplatelet treatment to aspirin. The studies involving the use of new oral antiplatelet agents that are more potent, predictable and f...

Full description

Bibliographic Details
Main Author: Rasim Enar
Format: Article
Language:English
Published: KARE Publishing 2013-04-01
Series:Türk Kardiyoloji Derneği Arşivi
Subjects:
acute coronary syndrome/drug therapy
aspirin/therapeutic use; drug therapy
combination; hemorrhage/chemically induced; clopidogrel; myocardial infarction/epidemiology; prasugrel; ticagrelor; platelet aggregation inhibitors.
Online Access:https://jag.journalagent.com/z4/download_fulltext.asp?pdir=tkd&un=TKDA-42716

Internet

https://jag.journalagent.com/z4/download_fulltext.asp?pdir=tkd&un=TKDA-42716

Similar Items